These findings were confirmed in a separate study in which a single CD28 co-stimulatory domain was most effective in triggering immediate cytotoxicity, but the inclusion of 4-1BB or OX40 co-stimulation yielded a longer lasting anti-tumor response. This evidence concerns the gene TNFRSF9 and neoplasm.